* Conmed Corp CNMD.N reported quarterly adjusted earnings
of 90
cents per share for the quarter ended in September. The mean
expectation of eight analysts for the quarter was for earnings
of 83 cents per share.
* Revenue rose 10.7% to $304.58 million from a year ago;
analysts
expected $300.91 million.
* Conmed Corp's reported EPS for the quarter was 50 cents.
* The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Conmed Corp shares had fallen by 6.2% this quarter and
gained 6.8% so far this year.
* The company reported quarterly net income of $15.84
million.
* Wall Street's median 12-month price target for Conmed Corp
is
$136.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
October 25 at 09:36 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.83 0.90 Beat
Jun. 30 2023 0.79 0.83 Beat
Mar. 31 2023 0.60 0.66 Beat
Dec. 31 2022 0.90 0.42 Missed